Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Review
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Metal−organic frameworks (MOFs) are a novel class of porous hybrid organic−inorganic materials that have attracted increasing attention over the past decade. MOFs can be used in chemical engineering, materials science, and chemistry applications. Recently, these structures have been thoroughly studied as promising platforms for biomedical applications. Due to their unique physical and chemical properties, they are regarded as promising candidates for disease diagnosis and drug delivery. Their well-defined structure, high porosity, tunable frameworks, wide range of pore shapes, ultrahigh surface area, relatively low toxicity, and easy chemical functionalization have made them the focus of extensive research. This review highlights the up-to-date progress of MOFs as potential platforms for disease diagnosis and drug delivery for a wide range of diseases such as cancer, diabetes, neurological disorders, and ocular diseases. A brief description of the synthesis methods of MOFs is first presented. Various examples of MOF-based sensors and DDSs are introduced for the different diseases. Finally, the challenges and perspectives are discussed to provide context for the future development of MOFs as efficient platforms for disease diagnosis and drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Chemistry and Applications of Metal-Organic Frameworks
Furukawa, H., Cordova, K. E., O’Keeffe, M., & Yaghi, O. M. (2013) · Science · doi:10.1126/science.1230444 · Cited by 16,945 · cited 1×
“MOFs, also known as porous coordination polymers (PCPs) [44,45], are a type of porous crystalline material that can be easily tuned, owing to the extended network structures constructed by the self-assembly of inorganic metal clusters and organic ligands [46].”
BackgroundEddaoudi, M., Kim, J., Rosi, N., Vodak, D., Wachter, J., O'Keeffe, M., & Yaghi, O. M. (2002) · Science · doi:10.1126/science.1067208 · Cited by 8,132 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundMetal-organic framework materials as catalysts
Lee, J., Farha, O. K., Roberts, J., Scheidt, K. A., Nguyen, S. T., & Hupp, J. T. (2009) · Chemical Society Reviews · doi:10.1039/b807080f · Cited by 7,969 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundNano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684 · cited 3×
“Many of these composites are ideal candidates for treating acute diseases such as cancer and diabetes, as well as kidney, cardiovascular, and microbial diseases [1].”
BackgroundInfluentialStock, N., & Biswas, S. (2012) · Chemical Reviews · doi:10.1021/cr200304e · Cited by 5,045 · cited 5×
“Advantages of this method include rapid crystallization [99], easy morphology control [100], high product purity [88], phase selectivity [101], and particle size reduction [88,102].”
BackgroundMethodInfluentialCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Metal–Organic Frameworks in Biomedicine
Horcajada, P., Gref, R., Baati, T., Allan, P. K., Maurin, G., Couvreur, P., Férey, G., Morris, R. E., & Serre, C. (2012) · Chemical Reviews · doi:10.1021/cr200256v · Cited by 4,168
Hydrogen Storage in Metal–Organic Frameworks
Suh, M. P., Park, H. J., Prasad, T. K., & Lim, D.-W. (2012) · Chemical Reviews · doi:10.1021/cr200274s · Cited by 3,689 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundBiodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Millward, A. R., & Yaghi, O. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0570032 · Cited by 2,876
Metal–organic frameworks—prospective industrial applications
Mueller, U., Schubert, M., Teich, F., Puetter, H., Schierle-Arndt, K., & Pastré, J. (2006) · J. Mater. Chem. · doi:10.1039/b511962f · Cited by 2,325 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodEngineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Metal–organic frameworks for artificial photosynthesis and photocatalysis
Zhang, T., & Lin, W. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00103f · Cited by 2,163 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundA review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Metal−Organic Frameworks with Functional Pores for Recognition of Small Molecules
Chen, B., Xiang, S., & Qian, G. (2010) · Accounts of Chemical Research · doi:10.1021/ar100023y · Cited by 2,033 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundApplications of Ultrasound to the Synthesis of Nanostructured Materials
Bang, J. H., & Suslick, K. S. (2010) · Advanced Materials · doi:10.1002/adma.200904093 · Cited by 1,895
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Emerging Multifunctional Metal–Organic Framework Materials
Li, B., Wen, H., Cui, Y., Zhou, W., Qian, G., & Chen, B. (2016) · Advanced Materials · doi:10.1002/adma.201601133 · Cited by 1,587 · cited 1×
“MOFs, also known as porous coordination polymers (PCPs) [44,45], are a type of porous crystalline material that can be easily tuned, owing to the extended network structures constructed by the self-assembly of inorganic metal clusters and organic ligands [46].”
BackgroundEffective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577 · cited 10×
“Nanocarriers Structures Advantages Disadvantages References Liposomes (organic) Bioc mpatibility, biodegradability, lower t xicity, prevention of drug degradation, reduction in side effects when encapsulating therapeutic agents, targeted drug delivery to diseased tissues, capable of elivering both hydr philic and hydr…”
BackgroundInfluentialTaylor-Pashow, K. M. L., Della Rocca, J., Xie, Z., Tran, S., & Lin, W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906198y · Cited by 1,522
Medical application of functionalized magnetic nanoparticles
Ito, A., Shinkai, M., Honda, H., & Kobayashi, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.1 · Cited by 1,470
Enzyme–MOF (metal–organic framework) composites
Lian, X., Fang, Y., Joseph, E., Wang, Q., Li, J., Banerjee, S., Lollar, C., Wang, X., & Zhou, H.-C. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00058h · Cited by 1,387 · cited 3×
“, surface areas of 1000 to 10,000 m2/g) th t increase the loading of biomolecules and the enc psulation of various types of pharmaceuticals [58], and adjustabl pore sizes w th diam ters less than 2 n , i i r ro s structures that determine the size of the molecu s that can fit in the por s [59]; (2) open architectures,…”
BackgroundSonochemical synthesis of nanomaterials
Xu, H., Zeiger, B. W., & Suslick, K. S. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35282f · Cited by 1,161
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Stimuli-Responsive Polymersomes for Programmed Drug Delivery
Meng, F., Zhong, Z., & Feijen, J. (2009) · Biomacromolecules · doi:10.1021/bm801127d · Cited by 1,122
Room temperature synthesis of metal-organic frameworks: MOF-5, MOF-74, MOF-177, MOF-199, and IRMOF-0
Tranchemontagne, D. J., Hunt, J. R., & Yaghi, O. M. (2008) · Tetrahedron · doi:10.1016/j.tet.2008.06.036 · Cited by 1,091
Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery
Rapoport, N. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.009 · Cited by 1,002
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998 · cited 2×
“, surface areas of 1000 to 10,000 m2/g) that increase the loading of biomolecules and the encapsulation of various types of pharmaceuticals [58], and adjustable pore sizes with diameters less than 2 nm, making them microporous structures that determine the size of the molecules that can fit in the pores [59]; (2) open…”
BackgroundA review on metal-organic frameworks: Synthesis and applications
Safaei, M., Foroughi, M. M., Ebrahimpoor, N., Jahani, S., Omidi, A., & Khatami, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.007 · Cited by 943 · cited 3×
“salts, it is considered safer, more eco-friendly, and gives opportunities for synthesizing modern materials, as water is the only byproduct produced by metal oxides [85,103].”
BackgroundMethodStructuring of metal–organic frameworks at the mesoscopic/macroscopic scale
Furukawa, S., Reboul, J., Diring, S., Sumida, K., & Kitagawa, S. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00106k · Cited by 897
A Single‐Atom Nanozyme for Wound Disinfection Applications
Xu, B., Wang, H., Wang, W., Gao, L., Li, S., Pan, X., Wang, H., Yang, H., Meng, X., Wu, Q., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201813994 · Cited by 860
Mishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 749
The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis
Gelperina, S., Kisich, K., Iseman, M. D., & Heifets, L. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-613pp · Cited by 745 · cited 1×
“Nanostructures are present in various configurations such as nanofibers, nanoparticles, nanotubes, and nanocomposites, which efficiently help in diagnosing [12] and treating different diseases [10,13,14].”
BackgroundLu, K., He, C., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508679h · Cited by 745
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723 · cited 5×
“, surface areas of 1000 to 10,000 m2/g) that increase the loading of biomolecules and the encapsulation of various types of pharmaceuticals [58], and adjustable pore sizes with diameters less than 2 nm, making them microporous structures that determine the size of the molecules that can fit in the pores [59]; (2) open…”
BackgroundInfluentialZeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle
Sun, C.-Y., Qin, C., Wang, X.-L., Yang, G.-S., Shao, K.-Z., Lan, Y.-Q., Su, Z.-M., Huang, P., Wang, C.-G., & Wang, E.-B. (2012) · Dalton Transactions · doi:10.1039/c2dt30357d · Cited by 710
Synthesis of metal-organic frameworks: A mini review
Lee, Y.-R., Kim, J., & Ahn, W.-S. (2013) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-013-0140-6 · Cited by 705 · cited 5×
“The reaction time is shortened to a few hours or minutes by using microwaves that have a frequency range from 300 MHz to 300 GHz, without deteriorating the quality of the product [67].”
BackgroundMethodInfluentialQiu, S., & Zhu, G. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.07.020 · Cited by 679 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodApplication of zirconium MOFs in drug delivery and biomedicine
Abánades Lázaro, I., & Forgan, R. S. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.09.009 · Cited by 678
Solvent-free synthesis of a microporous metal–organic framework
Pichon, A., Lazuen-Garay, A., & James, S. L. (2006) · CrystEngComm · doi:10.1039/b513750k · Cited by 665 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodNanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine
Simon‐Yarza, T., Mielcarek, A., Couvreur, P., & Serre, C. (2018) · Advanced Materials · doi:10.1002/adma.201707365 · Cited by 648
Microwave Synthesis of Nanoporous Materials
Tompsett, G. A., Conner, W. C., & Yngvesson, K. S. (2006) · ChemPhysChem · doi:10.1002/cphc.200500449 · Cited by 643 · cited 1×
“Some examples of these materials include zeolites, manganese oxides, mesoporous molecular sieves, aluminophosphates, and, more recently, silico-aluminophosphates and other phosphates [95,96].”
BackgroundSolvent-free synthesis of metal complexes
Garay, A. L., Pichon, A., & James, S. L. (2007) · Chemical Society Reviews · doi:10.1039/b600363j · Cited by 638
Microwave-Assisted Synthesis of Metal–Organic Frameworks
Klinowski, J., Almeida Paz, F. A., Silva, P., & Rocha, J. (2011) · Dalton Trans. · doi:10.1039/c0dt00708k · Cited by 598 · cited 1×
“This happens because the microwave radiates enough energy to overcome the activation energy barrier, which takes less time to complete the reaction when compared to conventional heating [97,98].”
BackgroundSonochemical synthesis of MOF-5
Son, W.-J., Kim, J., Kim, J., & Ahn, W.-S. (2008) · Chemical Communications · doi:10.1039/b814740j · Cited by 558 · cited 1×
“As a result of the cavitation breakdown, an increase in the temperature (5000–25,000 K) and pressure (1000 atm), great heating/cooling rates, and rapid shock waves occur in the liquid around the bubble [80,106].”
BackgroundMetal–Organic Framework Derived Nanozymes in Biomedicine
Wang, D., Jana, D., & Zhao, Y. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00268 · Cited by 540
Metal-organic frameworks for advanced drug delivery
He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528
The role of metal–organic frameworks in a carbon-neutral energy cycle
Schoedel, A., Ji, Z., & Yaghi, O. M. (2016) · Nature Energy · doi:10.1038/nenergy.2016.34 · Cited by 516 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundMetal–organic framework composites: from fundamentals to applications
Li, S., & Huo, F. (2015) · Nanoscale · doi:10.1039/c5nr00518c · Cited by 510
A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine
Jahangirian, H., Ghasemian lemraski, E., Webster, T. J., Rafiee-Moghaddam, R., & Abdollahi, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s127683 · Cited by 496 · cited 1×
“In the past years, extensive investigations have been carried out on nanocarriers as they have great potential in the drug delivery field; they can encapsulate drugs or conjugate therapeutic drugs to their surface and transport them preferentially to certain tissues, where they can release their cargo [21].”
BackgroundShen, L., Wu, W., Liang, R., Lin, R., & Wu, L. (2013) · Nanoscale · doi:10.1039/c3nr03153e · Cited by 483 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodMechanochemistry: the varied applications of mechanical bond-breaking
Kaupp, G. (2009) · CrystEngComm · doi:10.1039/b810822f · Cited by 456
Li, Z.-Q., Qiu, L.-G., Xu, T., Wu, Y., Wang, W., Wu, Z.-Y., & Jiang, X. (2009) · Materials Letters · doi:10.1016/j.matlet.2008.09.010 · Cited by 448 · cited 1×
“[82] utilized the ultrasonic method to synthesize a 3D metal−organic framework Cu3(BTC)2.”
MethodChen, Y., Li, P., Modica, J. A., Drout, R. J., & Farha, O. K. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02089 · Cited by 447
Bhatia, S. (2016) · Natural Polymer Drug Delivery Systems · doi:10.1007/978-3-319-41129-3_2 · Cited by 446
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444 · cited 11×
“Nanocarriers Structures Advantages Disadvantages References Liposomes (organic) Bioc mpatibility, biodegradability, lower t xicity, prevention of drug degradation, reduction in side effects when encapsulating therapeutic agents, targeted drug delivery to diseased tissues, capable of elivering both hydr philic and hydr…”
BackgroundInfluentialOvercoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies
Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 440 · cited 1×
“Moreover, other non-covalent adsorption methods include hydrogen bonding, ion−ion electrostatic interactions, π–π stacking, halogen bonding, van der Waals interactions, and coordination bonding [25].”
BackgroundMechanochemistry: Toward green synthesis of metal–organic frameworks
Głowniak, S., Szczęśniak, B., Choma, J., & Jaroniec, M. (2021) · Materials Today · doi:10.1016/j.mattod.2021.01.008 · Cited by 435 · cited 6×
“The apparatus used has a pressure and temperature controller as well as tunable power outputs [66].”
BackgroundMethodInfluentialChiral Nanoporous Metal‐Organic Frameworks with High Porosity as Materials for Drug Delivery
Sun, C., Qin, C., Wang, C., Su, Z., Wang, S., Wang, X., Yang, G., Shao, K., Lan, Y., & Wang, E. (2011) · Advanced Materials · doi:10.1002/adma.201102538 · Cited by 429
A Cooperative Copper Metal–Organic Framework‐Hydrogel System Improves Wound Healing in Diabetes
Xiao, J., Chen, S., Yi, J., Zhang, H. F., & Ameer, G. A. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604872 · Cited by 428
Wang, B., Yang, Q., Guo, C., Sun, Y., Xie, L.-H., & Li, J.-R. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b00918 · Cited by 423
Ke, F., Yuan, Y.-P., Qiu, L.-G., Shen, Y.-H., Xie, A.-J., Zhu, J.-F., Tian, X.-Y., & Zhang, L.-D. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm01770a · Cited by 403
Metal–organic frameworks for biosensing and bioimaging applications
Wang, H.-S. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.08.015 · Cited by 403
Xiao, J., Zhu, Y., Huddleston, S., Li, P., Xiao, B., Farha, O. K., & Ameer, G. A. (2018) · ACS Nano · doi:10.1021/acsnano.7b01850 · Cited by 396
Zhang, J.-W., Zhang, H.-T., Du, Z.-Y., Wang, X., Yu, S.-H., & Jiang, H.-L. (2014) · Chem. Commun. · doi:10.1039/c3cc48398c · Cited by 384
Amorphous metal–organic frameworks for drug delivery
Orellana-Tavra, C., Baxter, E. F., Tian, T., Bennett, T. D., Slater, N. K. H., Cheetham, A. K., & Fairen-Jimenez, D. (2015) · Chemical Communications · doi:10.1039/c5cc05237h · Cited by 378
Pluronic® block copolymers: novel functional molecules for gene therapy
Kabanov, A. V., Lemieux, P., Vinogradov, S., & Alakhov, V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00018-2 · Cited by 375 · cited 2×
“Cells can absorb nanoparticles much more than larger particles ranging in size between 1 to 10 μm [18,23].”
BackgroundCai, W., Gao, H., Chu, C., Wang, X., Wang, J., Zhang, P., Lin, G., Li, W., Liu, G., & Chen, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b11579 · Cited by 357
Mechanical Force-Triggered Drug Delivery
Zhang, Y., Yu, J., Bomba, H. N., Zhu, Y., & Gu, Z. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00369 · Cited by 354
Nanomedicine and drug delivery: a mini review
Mirza, A. Z., & Siddiqui, F. A. (2014) · International Nano Letters · doi:10.1007/s40089-014-0094-7 · Cited by 353 · cited 1×
“Cells can absorb nanoparticles much more than larger particles ranging in size between 1 to 10 μm [18,23].”
BackgroundSingle walled carbon nanotubes as drug delivery vehicles: Targeting doxorubicin to tumors
Meng, L., Zhang, X., Lu, Q., Fei, Z., & Dyson, P. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.004 · Cited by 336 · cited 1×
“This usually leads to damaging healthy tissues [2], burst release [3], and cardiotoxicity effects [4,5].”
BackgroundIncorporation of biomolecules in Metal-Organic Frameworks for advanced applications
An, H., Li, M., Gao, J., Zhang, Z., Ma, S., & Chen, Y. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.01.001 · Cited by 336 · cited 4×
“, surface areas of 1000 to 10,000 m2/g) th t increase the loading of biomolecules and the enc psulation of various types of pharmaceuticals [58], and adjustabl pore sizes w th diam ters less than 2 n , i i r ro s structures that determine the size of the molecu s that can fit in the por s [59]; (2) open architectures,…”
BackgroundInfluentialMao, D., Hu, F., Kenry, Ji, S., Wu, W., Ding, D., Kong, D., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201706831 · Cited by 334
Adsorption, separation, and catalytic properties of densified metal-organic frameworks
Nandasiri, M. I., Jambovane, S. R., McGrail, B. P., Schaef, H. T., & Nune, S. K. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.12.004 · Cited by 324 · cited 1×
“MOFs, also known as porous coordination polymers (PCPs) [44,45], are a type of porous crystalline material that can be easily tuned, owing to the extended network structures constructed by the self-assembly of inorganic metal clusters and organic ligands [46].”
BackgroundZhao, H.-X., Zou, Q., Sun, S.-K., Yu, C., Zhang, X., Li, R.-J., & Fu, Y.-Y. (2016) · Chemical Science · doi:10.1039/c6sc01359g · Cited by 320
Nanoscale Metal–Organic Frameworks for Ratiometric Oxygen Sensing in Live Cells
Xu, R., Wang, Y., Duan, X., Lu, K., Micheroni, D., Hu, A., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b13458 · Cited by 319
Regeneration, degradation, and toxicity effect of MOFs: Opportunities and challenges
Kumar, P., Anand, B., Tsang, Y. F., Kim, K.-H., Khullar, S., & Wang, B. (2019) · Environmental Research · doi:10.1016/j.envres.2019.05.019 · Cited by 319
Ma, W., Jiang, Q., Yu, P., Yang, L., & Mao, L. (2013) · Analytical Chemistry · doi:10.1021/ac401576u · Cited by 306
Recent progress in the synthesis of metal–organic frameworks
Sun, Y., & Zhou, H.-C. (2015) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/16/5/054202 · Cited by 296 · cited 2×
“The electrochemical synthesis of MOFs was first men ioned in 2005 by researchers at BASF [86], who synthesized HKUST-1 with the goal of eliminating anions, such as chloride, nitrate, and perchlorate through large-scale production processes utilizing MOFs [87,88].”
MethodNanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
Brambilla, D., Le Droumaguet, B., Nicolas, J., Hashemi, S. H., Wu, L.-P., Moghimi, S. M., Couvreur, P., & Andrieux, K. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.03.008 · Cited by 294
Hierarchically porous metal–organic frameworks: synthetic strategies and applications
Feng, L., Wang, K.-Y., Lv, X.-L., Yan, T.-H., & Zhou, H.-C. (2020) · National Science Review · doi:10.1093/nsr/nwz170 · Cited by 290 · cited 3×
“, surface areas of 1000 to 10,000 m2/g) th t increase the loading of biomolecules and the enc psulation of various types of pharmaceuticals [58], and adjustabl pore sizes w th diam ters less than 2 n , i i r ro s structures that determine the size of the molecu s that can fit in the por s [59]; (2) open architectures,…”
BackgroundZeolitic Imidazolate Framework as Formaldehyde Gas Sensor
Chen, E.-X., Yang, H., & Zhang, J. (2014) · Inorganic Chemistry · doi:10.1021/ic500474j · Cited by 290
Zeng, J., Zhang, M., Peng, M., Gong, D., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201705451 · Cited by 287
Quantum Dot Biosensors for Ultrasensitive Multiplexed Diagnostics
Geißler, D., Charbonnière, L. J., Ziessel, R. F., Butlin, N. G., Löhmannsröben, H., & Hildebrandt, N. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906399 · Cited by 283 · cited 2×
“, surface areas of 1000 to 10,000 m2/g) that increase the loading of biomolecules and the encapsulation of various types of pharmaceuticals [58], and adjustable pore sizes with diameters less than 2 nm, making them microporous structures that determine the size of the molecules that can fit in the pores [59]; (2) open…”
BackgroundSurface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy
Kang, T., Li, F., Baik, S., Shao, W., Ling, D., & Hyeon, T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.013 · Cited by 280
Verma, M. L., Barrow, C. J., & Puri, M. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4535-9 · Cited by 279 · cited 1×
“In addition, these nanostructures are used as carriers or transporting agents for drugs [15], proteins [16], vaccines [17], genes [18], and enzymes [19].”
BackgroundFacile synthesis of MOF-177 by a sonochemical method using 1-methyl-2-pyrrolidinone as a solvent
Jung, D.-W., Yang, D.-A., Kim, J., Kim, J., & Ahn, W.-S. (2010) · Dalton Transactions · doi:10.1039/b925088c · Cited by 264
Sun, Q., Bi, H., Wang, Z., Li, C., Wang, X., Xu, J., Zhu, H., Zhao, R., He, F., Gai, S., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119473 · Cited by 264
Gao, X., Zhai, M., Guan, W., Liu, J., Liu, Z., & Damirin, A. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14795 · Cited by 257
Kundu, T., Mitra, S., Patra, P., Goswami, A., Díaz Díaz, D., & Banerjee, R. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201402244 · Cited by 251
Potentials of new nanocarriers for dermal and transdermal drug delivery
Neubert, R. H. H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.003 · Cited by 250
Nanotechnology in Drug Delivery
(2009) · Springer eBooks · doi:10.1007/978-0-387-77667-5 · Cited by 247
Recent Advances in Drug Delivery Systems
Martinho, N., Damgé, C., & Reis, C. P. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225062 · Cited by 244
Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications
Liu, M., Du, H., Zhang, W., & Zhai, G. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.11.030 · Cited by 235
MOFBOTS: Metal–Organic‐Framework‐Based Biomedical Microrobots
Wang, X., Chen, X., Alcântara, C. C. J., Sevim, S., Hoop, M., Terzopoulou, A., de Marco, C., Hu, C., de Mello, A. J., Falcaro, P., et al. (2019) · Advanced Materials · doi:10.1002/adma.201901592 · Cited by 228
Constructing Redox-Responsive Metal–Organic Framework Nanocarriers for Anticancer Drug Delivery
Lei, B., Wang, M., Jiang, Z., Qi, W., Su, R., & He, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b19693 · Cited by 218
Zn2+‐Triggered Drug Release from Biocompatible Zirconium MOFs Equipped with Supramolecular Gates
Tan, L., Li, H., Zhou, Y., Zhang, Y., Feng, X., Wang, B., & Yang, Y. (2015) · Small · doi:10.1002/smll.201500155 · Cited by 216
pH‐Dependent Proton Conducting Behavior in a Metal–Organic Framework Material
Phang, W. J., Lee, W. R., Yoo, K., Ryu, D. W., Kim, B., & Hong, C. S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404164 · Cited by 216
Zr- and Hf-based nanoscale metal–organic frameworks as contrast agents for computed tomography
deKrafft, K. E., Boyle, W. S., Burk, L. M., Zhou, O. Z., & Lin, W. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm32299d · Cited by 198
Wuttke, S., Zimpel, A., Bein, T., Braig, S., Stoiber, K., Vollmar, A., Müller, D., Haastert‐Talini, K., Schaeske, J., Stiesch, M., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201600818 · Cited by 194
Song, Z., Wu, Y., Cao, Q., Wang, H., Wang, X., & Han, H. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800011 · Cited by 192
Supramolecular Interactions and Morphology Control in Microwave Synthesis of Nanoporous Materials
Park, S.-E., Chang, J.-S., Hwang, Y. K., Kim, D. S., Jhung, S. H., & Hwang, J. S. (2004) · Catalysis Surveys from Asia · doi:10.1023/b:cats.0000026990.25778.a8 · Cited by 190 · cited 2×
“The vessel is then put in a microwave and heated at a certain temperature for a proper time [66,95,99].”
BackgroundMethodZhang, P., Li, Y., Tang, Y., Shen, H., Li, J., Yi, Z., Ke, Q., & Xu, H. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01792 · Cited by 189
Microwave Fabrication of MFI Zeolite Crystals with a Fibrous Morphology and Their Applications
Hwang, Y. K., Chang, J., Park, S., Kim, D. S., Kwon, Y., Jhung, S. H., Hwang, J., & Park, M. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461403 · Cited by 186
Abazari, R., Mahjoub, A. R., & Shariati, J. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2018.12.030 · Cited by 181
Kim, K., Lee, S., Jin, E., Palanikumar, L., Lee, J. H., Kim, J. C., Nam, J. S., Jana, B., Kwon, T.-H., Kwak, S. K., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05736 · Cited by 181
Ahmadi, M., Ayyoubzadeh, S. M., Ghorbani-Bidkorbeh, F., Shahhosseini, S., Dadashzadeh, S., Asadian, E., Mosayebnia, M., & Siavashy, S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06914 · Cited by 178
Babu, R., Roshan, R., Kathalikkattil, A. C., Kim, D. W., & Park, D.-W. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12458 · Cited by 177
Gwon, K., Han, I., Lee, S., Kim, Y., & Lee, D. N. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c03187 · Cited by 177
Tan, L.-L., Song, N., Zhang, S. X.-A., Li, H., Wang, B., & Yang, Y.-W. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb01789k · Cited by 174
Wang, J., Fan, Y., Tan, Y., Zhao, X., Zhang, Y., Cheng, C., & Yang, M. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b15452 · Cited by 173
Lin, S., Liu, X., Tan, L., Cui, Z., Yang, X., Yeung, K. W. K., Pan, H., & Wu, S. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b04810 · Cited by 172
Recent Progress on Nanostructures for Drug Delivery Applications
Lu, H., Wang, J., Wang, T., Zhong, J., Bao, Y., & Hao, H. (2016) · Journal of Nanomaterials · doi:10.1155/2016/5762431 · Cited by 170 · cited 3×
“They act as bui ding blocks in nanostructur s, wher their distribution and cont nt are precisely controlled [24].”
BackgroundInfluentialNanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery
Ochekpe, N., Olorunfemi, P., & Ngwuluka, N. C. (2009) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v8i3.44547 · Cited by 168
Luzuriaga, M. A., Welch, R. P., Dharmarwardana, M., Benjamin, C. E., Li, S., Shahrivarkevishahi, A., Popal, S., Tuong, L. H., Creswell, C. T., & Gassensmith, J. J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20504 · Cited by 166 · cited 1×
“In addition, these nanostructures are used as carriers or transporting agents for drugs [15], proteins [16], vaccines [17], genes [18], and enzymes [19].”
BackgroundpH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery
Zhang, C., Hong, S., Liu, M.-D., Yu, W.-Y., Zhang, M.-K., Zhang, L., Zeng, X., & Zhang, X.-Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.038 · Cited by 165
Masoomi, M. Y., Morsali, A., & Junk, . C. (2014) · CrystEngComm · doi:10.1039/c4ce01783h · Cited by 165 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodCampagnol, N., Souza, E. R., De Vos, D. E., Binnemans, K., & Fransaer, J. (2014) · Chem. Commun. · doi:10.1039/c4cc05742b · Cited by 164 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodHost–Guest Interactions in Fe(III)-Trimesate MOF Nanoparticles Loaded with Doxorubicin
Anand, R., Borghi, F., Manoli, F., Manet, I., Agostoni, V., Reschiglian, P., Gref, R., & Monti, S. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp503809w · Cited by 162 · cited 2×
“, surface areas of 1000 to 10,000 m2/g) th t increase the loading of biomolecules and the enc psulation of various types of pharmaceuticals [58], and adjustabl pore sizes w th diam ters less than 2 n , i i r ro s structures that determine the size of the molecu s that can fit in the por s [59]; (2) open architectures,…”
BackgroundBian, R., Wang, T., Zhang, L., Li, L., & Wang, C. (2015) · Biomaterials Science · doi:10.1039/c5bm00186b · Cited by 161
Metal-organic frameworks-based nanozymes for combined cancer therapy
Ding, S., He, L., Bian, X., & Tian, G. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100920 · Cited by 158
Firouzjaei, M. D., Shamsabadi, A. A., Gh., M. S., Rahimpour, A., & Soroush, M. (2018) · Advanced Materials Interfaces · doi:10.1002/admi.201701365 · Cited by 154
Therapeutic Nanocarriers with Hydrogen Peroxide-Triggered Drug Release for Cancer Treatment
Liu, J., Pang, Y., Zhu, Z., Wang, D., Li, C., Huang, W., Zhu, X., & Yan, D. (2013) · Biomacromolecules · doi:10.1021/bm4002574 · Cited by 151
Carriers in the Topical Treatment of Skin Disease
Körting, H. C., & Schäfer‐Korting, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_15 · Cited by 146
Functionalization of mixed ligand metal-organic frameworks as the transport vehicles for drugs
Sun, K., Li, L., Yu, X., Liu, L., Meng, Q., Wang, F., & Zhang, R. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.09.068 · Cited by 146
Pandey, A. P., Dhas, N. L., Deshmukh, P. K., Caro, C., Patil, P. O., García‐Martín, M. L., Padya, B. S., Nikam, A. N., Mehta, T. A., & Mutalik, S. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213212 · Cited by 144
Wang, S., Sun, Zhu, Du, Liu, & Qian, W.-Y. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34773 · Cited by 135
Metal-organic framework-based nanomaterials for biomedical applications
Zhang, S., Pei, X., Gao, H., Chen, S., & Wang, J. (2019) · Chinese Chemical Letters · doi:10.1016/j.cclet.2019.11.036 · Cited by 133 · cited 7×
“, surface areas of 1000 to 10,000 m2/g) that increase the loading of biomolecules and the encapsulation of various types of pharmaceuticals [58], and adjustable pore sizes with diameters less than 2 nm, making them microporous structures that determine the size of the molecules that can fit in the pores [59]; (2) open…”
BackgroundInfluentialWei, X., Guo, J., Lian, H., Sun, X., & Liu, B. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.129205 · Cited by 130
Gándara-Loe, J., Souza, B. E., Missyul, A. B., Durango-Giraldo, G., Tan, J., & Silvestre‐Albero, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07517 · Cited by 129
Wu, M., Yan, H., Gao, J., Cheng, Y., Yang, J., Wu, J., Gong, B., Zhang, H., & Yang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b13758 · Cited by 127
Smart nanocarriers-based drug delivery for cancer therapy: An innovative and developing strategy
Huda, S., Alam, A., & Sharma, P. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102018 · Cited by 127
Toxicity of nanoscale metal organic frameworks: a perspective
Sajid, M. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-7053-y · Cited by 126
Liu, Y., Gong, C. S., Dai, Y., Yang, Z., Yu, G., Liu, Y., Zhang, M., Lin, L., Tang, W., Zhou, Z., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119365 · Cited by 124
Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle
Stefaniak, K. R., Epley, C. C., Novak, J. J., McAndrew, M. L., Cornell, H. D., Zhu, J., McDaniel, D. K., Davis, J. L., Allen, I. C., Morris, A. J., et al. (2018) · Chemical Communications · doi:10.1039/c8cc01601a · Cited by 123
Wang, X., Qin, T., Bao, S., Zhang, Y., Shen, X. J., Zheng, L., & Zhu, D. (2016) · Journal of Materials Chemistry A · doi:10.1039/c6ta06792a · Cited by 120
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
Vauthier, C., Labarre, D., & Ponchel, G. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701603372 · Cited by 119 · cited 1×
“Nanostructures are present in various configurations such as nanofibers, nanoparticles, nanotubes, and nanocomposites, which efficiently help in diagnosing [12] and treating different diseases [10,13,14].”
BackgroundMetal-organic frameworks for virus detection
Wang, Y., Hu, Y., He, Q., Yan, J., Xiong, H., Wen, N., Cai, S., Peng, D., Liu, Y., & Liu, Z. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112604 · Cited by 114
Room temperature synthesis of metal organic framework MOF-2
Getachew, N., Chebude, Y., Dı́az, I., & Sánchez‐Sánchez, M. (2014) · Journal of Porous Materials · doi:10.1007/s10934-014-9823-6 · Cited by 112
Pirzadeh, K., Ghoreyshi, A. A., Rahimnejad, M., & Mohammadi, M. (2018) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-017-0340-6 · Cited by 112 · cited 1×
“These compounds are first reduced and then slightly used to solve the issue [89,90].”
BackgroundZhou, Y., Liu, L., Cao, Y., Yu, S., He, C., & Chen, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c04303 · Cited by 111
Endogenous Stimuli-responsive Nanocarriers for Drug Delivery
Chen, H., Liu, D., & Guo, Z. (2016) · Chemistry Letters · doi:10.1246/cl.151176 · Cited by 109
Metal-organic frameworks, NH2-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Kim, S.-N., Park, C. G., Huh, B. K., Lee, S. H., Min, C. H., Lee, Y. Y., Kim, Y. K., Park, K. H., & Choy, Y. B. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.023 · Cited by 108
Metal–Organic Frameworks as Drug Delivery Platforms for Ocular Therapeutics
Gándara-Loe, J., Ortuño‐Lizarán, I., Fernández‐Sánchez, L., ALIO, J. L., Cuenca, N., Vega-Estrada, A., & Silvestre‐Albero, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20222 · Cited by 104
Xing, K., Fan, R., Wang, F., Nie, H., Du, X., Gai, S., Wang, P., & Yang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b06270 · Cited by 101
Esfahanian, M., Ghasemzadeh, M. A., & Razavian, S. M. H. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1617729 · Cited by 100
Saeed, T., Naeem, A., Ud Din, I., Alotaibi, M. A., Alharthi, A. I., Wali Khan, I., Huma Khan, N., & Malik, T. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.105579 · Cited by 95 · cited 5×
“Moreover, it is eco-friendly, easy to use, can be applied at ambient temperature, and involves a substantial reduction in synthesis time compared to other traditional synthesis techniques [85,91].”
BackgroundMethodInfluentialYang, J., Feng, W., Liang, K., Chen, C., & Cai, C. (2020) · Talanta · doi:10.1016/j.talanta.2020.120744 · Cited by 94
Zhao, J., Yin, F., Ji, L., Wang, C., Shi, C., Liu, X., Yang, H., Wang, X., & Kong, L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c11064 · Cited by 92
Rahmati, Z., Abdi, J., Vossoughi, M., & Alemzadeh, I. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109555 · Cited by 92
Organic nanocarriers for cancer drug delivery
López-Dávila, V., Seifalian, A. M., & Loizidou, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.011 · Cited by 91
Biomedical Integration of Metal–Organic Frameworks
Banerjee, S., Lollar, C., Xiao, Z., Fang, Y., & Zhou, H.-C. “. (2020) · Trends in Chemistry · doi:10.1016/j.trechm.2020.01.007 · Cited by 90
Li, J., Lv, F., Li, J., Li, Y., Gao, J., Luo, J., Xue, F., Ke, Q., & Xu, H. (2020) · Nano Research · doi:10.1007/s12274-020-2846-1 · Cited by 90
Zhang, Y., Lü, Y., Lu, Y., Wang, G., & Liu, A. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.04.006 · Cited by 89 · cited 1×
“These applications include, but are not limited to, gas storage and separation [48,49], chemical separation [50], bioimaging [51,52], catalysis [53,54], water treatment [55], and energy [56,57].”
BackgroundJiang, P., Hu, Y., & Li, G. (2019) · Talanta · doi:10.1016/j.talanta.2019.03.057 · Cited by 89
Protective properties of melatonin-loaded nanoparticles against lipid peroxidation
Schaffazick, S. R., Pohlmann, A. R., de Cordova, C. A. S., Creczynski‐Pasa, T. B., & Guterres, S. S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.003 · Cited by 88
George, P., Das, R. K., & Chowdhury, P. (2019) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2019.02.028 · Cited by 88
Maßgeschneiderte Nanopartikel für den Wirkstofftransport in der Krebstherapie
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie · doi:10.1002/ange.201403036 · Cited by 86
Chang, X., Li, X., Qiao, X., Li, K., Xiong, Y., Li, X., Guo, T., Zhu, L., & Xue, Q. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127430 · Cited by 86
Iron-Based Metal-Organic Frameworks as a Theranostic Carrier for Local Tuberculosis Therapy
Wyszogrodzka, G., Dorożyński, P., Gil, B., Roth, W. J., Strzempek, M., Marszałek, B., Węglarz, W. P., Menaszek, E., Strzempek, W., & Kulinowski, P. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2425-2 · Cited by 83
Nanozymes—Hitting the Biosensing “Target”
Wu, Y., Darland, D. C., & Zhao, J. X. (2021) · Sensors · doi:10.3390/s21155201 · Cited by 81
Hollow Mesoporous Silica@Metal–Organic Framework and Applications for pH‐Responsive Drug Delivery
Jia, X., Yang, Z., Wang, Y., Chen, Y., Yuan, H., Chen, H., Xu, X., Gao, X., Liang, Z., Sun, Y., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800019 · Cited by 81
Peng, S., Liu, J.-S., Qin, Y., Wang, H., Cao, B., Lu, L., & Yu, X. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15037 · Cited by 80
Microwave Synthesis of the CPM‐5 Metal Organic Framework
Sabouni, R., Kazemian, H., & Rohani, S. (2012) · Chemical Engineering & Technology · doi:10.1002/ceat.201100626 · Cited by 79
Self-citationWang, D., He, H., Chen, X., Feng, S., Niu, Y., & Sun, D. (2009) · CrystEngComm · doi:10.1039/b910988a · Cited by 78 · cited 1×
“As shown in Figure 4, these methods include slow diffusion [68,69], electrochemical [70,71], microwave-assisted [72–74], mechanochemical [75,76], hydrothermal (solvothermal) [77,78], and sonochemical [79–82] techniques.”
MethodXue, Q., Ye, C., Zhang, M., Hu, X., & Cai, T. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.04.096 · Cited by 77
Why are nanomaterials different and how can they be appropriately regulated under REACH?
Schwirn, K., Tietjen, L., & Beer, I. (2014) · Environmental Sciences Europe · doi:10.1186/2190-4715-26-4 · Cited by 74
A biocompatible metal–organic framework as a pH and temperature dual-responsive drug carrier
Lin, W., Cui, Y., Yang, Y. L., Hu, Q., & Qian, G. (2018) · Dalton Transactions · doi:10.1039/c8dt03202e · Cited by 70
Li, H.-Y., Zhu, J., Wang, C., Qin, W., Hu, X., Tong, J., Yu, L., Zhang, G., Ren, X., Li, Z., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119649 · Cited by 69
Selective removal of dual dyes from aqueous solutions using a metal organic framework (MIL-53(Al))
Sharabati, M. A., & Sabouni, R. (2020) · Polyhedron · doi:10.1016/j.poly.2020.114762 · Cited by 61
Self-citationQiu, G.-H., Weng, Z.-H., Hu, P.-P., Duan, W., Xie, B., Sun, B., Tang, X., & Chen, J.-X. (2017) · Talanta · doi:10.1016/j.talanta.2017.12.045 · Cited by 60
A porous Cu(II)-based metal-organic framework carrier for pH-controlled anticancer drug delivery
Liu, W., Zhong, Y., Wang, X., Zhuang, C., Chen, J., Liu, D., Xiao, W., Pan, Y. H., Huang, J., & Liu, J. (2019) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2019.107675 · Cited by 59
Castro, G. A., Oréfice, R. L., Vilela, J. M. C., Andrade, M. S., & Ferreira, L. A. M. (2007) · Journal of Microencapsulation · doi:10.1080/02652040701288519 · Cited by 55
Strzempek, W., Menaszek, E., & Gil, B. (2019) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2019.02.018 · Cited by 53
Enzyme‐Driven Release of Loads from Nucleic Acid–Capped Metal–Organic Framework Nanoparticles
Chen, W., Luo, G., Sohn, Y. S., Nechushtai, R., & Willner, I. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805341 · Cited by 52
Chen, H., Li, R.-T., Wu, K.-Y., Hu, P.-P., Zhang, Z., Huang, N.-H., Zhang, W., & Chen, J.-X. (2019) · Talanta · doi:10.1016/j.talanta.2019.120596 · Cited by 51
Nanoporous Carbon Derived from MOF-5: A Superadsorbent for Copper Ions
Bakhtiari, N., & Azizian, S. (2018) · ACS Omega · doi:10.1021/acsomega.8b02278 · Cited by 50
Sharma, S., Sethi, K., & Roy, I. (2017) · New Journal of Chemistry · doi:10.1039/c7nj02032e · Cited by 49
Rebekah, A., Sivaselvam, S., Viswanathan, C., Prabhu, D., Gautam, R., & Ponpandian, N. (2020) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2020.125913 · Cited by 45
Metal–Organic Framework‐Derived Nickel/Cobalt‐Based Nanohybrids for Sensing Non‐Enzymatic Glucose
Wang, L., Hou, C., Yu, H., Zhang, Q., Li, Y., & Wang, H. (2020) · ChemElectroChem · doi:10.1002/celc.202001135 · Cited by 44
Polymer-associated liposomes as a novel delivery system for cyclodextrin-bound drugs
Lim, H. J., Cho, E. C., Shim, J., Kim, D., An, E. J., & Kim, J. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.01.025 · Cited by 44
Qu, J., Wang, Q., Chen, K., Luo, J., Zhou, Q., & Lin, J. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.06.015 · Cited by 43
Zhu, J., Tang, Y., Yang, Y. L., Li, B., Cui, Y., & Qian, G. (2019) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2019.109610 · Cited by 41
Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review
Karami, A., Mohamed, O., Ahmed, A., Husseini, G. A., & Sabouni, R. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210119093844 · Cited by 39 · cited 2×
“Lipid−polymer hybrid, ceramic−polymer hybrid, and metal−organic frameworks (MOFs) are among the examples of this kind of nanocarrier [3,28].”
BackgroundSelf-citationShi, Z., Chu, C., Zhang, Y., Su, Z., Lin, H., Pang, X., Wang, X., Liu, G., & Li, W. (2018) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2018.2636 · Cited by 38
Morsali, A., Hosseini‐Monfared, H., Morsali, A., & Janiak, C. (2014) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2014.06.005 · Cited by 38
Gold nanoparticle mediated delivery of fungal asparaginase against cancer cells
Baskar, G., George, G. B., Lalitha, K., & Chamundeeswari, M. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.02.007 · Cited by 37 · cited 1×
“In addition, these nanostructures are used as carriers or transporting agents for drugs [15], proteins [16], vaccines [17], genes [18], and enzymes [19].”
BackgroundHe, J., Li, C., Ye, J., Qiao, Y., & Gu, L. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102491 · Cited by 35
Thangavelu, M., Chamundeeswari, M., Sundaram, P., Baskar, G., Chandhuru, J., & Sastry, T. P. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.09.011 · Cited by 34 · cited 8×
“Nanocarriers Structures Advantages Disadvantages References Liposomes (organic) Bioc mpatibility, biodegradability, lower t xicity, prevention of drug degradation, reduction in side effects when encapsulating therapeutic agents, targeted drug delivery to diseased tissues, capable of elivering both hydr philic and hydr…”
BackgroundInfluentialZhang, X., Liu, L., Han, Z., Gao, M., & Yuan, D. (2015) · RSC Advances · doi:10.1039/c4ra11678j · Cited by 33
Inorganic Nanoparticles in Targeted Drug Delivery and Imaging
Santos, H. A., Bimbo, L. M., Peltonen, L., & Hirvonen, J. J. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_18 · Cited by 28 · cited 10×
“Nanocarriers Structures Advantages Disadvantages References Liposomes (organic) Bioc mpatibility, biodegradability, lower t xicity, prevention of drug degradation, reduction in side effects when encapsulating therapeutic agents, targeted drug delivery to diseased tissues, capable of elivering both hydr philic and hydr…”
BackgroundInfluentialSynthesis of ‘dual-key-and-lock’ drug carriers for imaging and improved drug release
Gao, H., Zhang, Y., Chi, B., Lin, C., Tian, F., Xu, M., Wang, Y., Xu, Z., Li, L., & Wang, J. (2020) · Nanotechnology · doi:10.1088/1361-6528/aba65a · Cited by 23
Wang, Y., Liu, W., Yuan, B., Yin, X., Li, Y., Li, Z., Cui, J., Yuan, X., & Li, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s225992 · Cited by 22
Recent progress in metal–organic frameworks for precaution and diagnosis of Alzheimer’s disease
Liao, Z., Zhang, J., Yu, E., & Cui, Y. (2018) · Polyhedron · doi:10.1016/j.poly.2018.06.013 · Cited by 21
Jin, T., Hwang, Y. K., Hong, D., Jhung, S. H., Hwang, J., Park, S.-E., Kim, Y. H., & Chang, J. (2007) · Research on Chemical Intermediates · doi:10.1163/156856707782565804 · Cited by 17 · cited 2×
“Some examples of these materials include zeolites, manganese oxides, mesoporous molecular sieves, aluminophosphates, and, more recently, silico-aluminophosphates and other phosphates [95,96].”
BackgroundNeurochemical Aspects of Neurological Disorders
Farooqui, A. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803603-7.00016-1 · Cited by 14
Fakharzadeh, S., Argani, H., Torbati, P. M., Dadashzadeh, S., Kalanaky, S., Nazaran, M. H., & Basiri, A. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126547 · Cited by 11
Unique attributes of metal-organic frameworks in drug delivery
Malik, P., Gupta, R., & Ameta, R. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822099-3.00016-2 · Cited by 6
Cited by
Advances in immunomodulatory MOFs for biomedical applications
Zhang, B., Chen, J., Zhu, Z., Zhang, X., & Wang, J. (2024) · Small · doi:10.1002/smll.202307299 · Cited by 31
Metadata
- Authors
- Al Sharabati, M., Sabouni, R., & Husseini, G. A.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2022-01-16
- Volume
- 12
- Issue
- 2
- Pages
- 277
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W4206303844
- Cited by
- 218
- References
- 199
- FWCI
- 13.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.